Concurrently with the TRCA buyout, Ipsen is acquiring full control of OBI-1, a recombinant porcine FVIII: <a href='read_msg.asp?message_id=29801165'>#msg-29801165</a> <!--Beg_Sig--> <a href=http://www.investorshub.com/boards/board.asp?board_id=1418>Let’s talk biotech!</a> “The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”